{"Year":[2014,2015,2016,2017,2018,2019,2020,2021,2014,2015,2016,2017,2018,2019,2020,2021,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019],"SERIES":["Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)"],"UNIT_MEASURE":["PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT","PT"],"Value":[86.0,82.0,78.0,75.0,73.0,73.0,73.0,73.0,92.0,88.0,78.0,80.0,76.0,76.0,76.0,76.0,null,null,null,null,null,null,null,null,null,null,null,null]}